Elmwood Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-16,646
| Closed | -$677K | – | 107 |
|
2023
Q3 | $677K | Sell |
16,646
-81
| -0.5% | -$3.3K | 0.33% | 85 |
|
2023
Q2 | $811K | Buy |
16,727
+845
| +5% | +$41K | 0.38% | 80 |
|
2023
Q1 | $783K | Buy |
15,882
+631
| +4% | +$31.1K | 0.37% | 83 |
|
2022
Q4 | $772K | Sell |
15,251
-200
| -1% | -$10.1K | 0.39% | 84 |
|
2022
Q3 | $776K | Sell |
15,451
-162
| -1% | -$8.14K | 0.39% | 77 |
|
2022
Q2 | $763K | Buy |
15,613
+1,057
| +7% | +$51.7K | 0.43% | 79 |
|
2022
Q1 | $875K | Buy |
14,556
+10,153
| +231% | +$610K | 0.45% | 75 |
|
2021
Q4 | $350K | Buy |
+4,403
| New | +$350K | 0.17% | 95 |
|
2021
Q2 | $12K | Buy |
+125
| New | +$12K | 0.01% | 250 |
|